Baxter International Inc (BAX)
Baxter International Inc (BAX) is a Healthcare stock tracked by StreetAlpha. BAX reports earnings on Thu, Oct 29, 2026. Analyst consensus is Hold, based on the latest ratings from 6 firms (0 buy, 5 hold, 1 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in BAX, 0% of them bullish and 100% bearish. In the past 30 days there were 6 dark pool prints.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 7 | Barclays | Initiated | Sell | — |
| Oct 5 | Citigroup | Target lowered | Hold | — |
| Jul 31 | TD Cowen | Target raised | Hold | — |
| Jul 31 | Wells Fargo | Maintained | Hold | — |
| Jul 31 | Stifel | Target raised | Hold | — |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BAX is in one of them and how their past BAX trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered BAX in an article yet. Here's the latest on the wider market.
BAX Congress Trades
All congress trades →| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Donald J TrumpExecutive branch | Sell | $15K – $50K | Jul 23, 2026 | Sep 22, 2026 | 61 d |
| Donald J TrumpExecutive branch | Buy | $1K – $15K | May 18, 2026 | Jul 1, 2026 | 44 d |
| Donald J TrumpExecutive branch | Sell | $1K – $15K | May 15, 2026 | Jul 1, 2026 | 47 d |
| Ro KhannaD · CA | Buy | $1K – $15K | May 1, 2026 | Jun 11, 2026 | 41 d |
| Michael McCaulR · TX | Buy | $15K – $50K | Mar 23, 2026 | Apr 8, 2026 | 16 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.





